GLOBAL INFERTILITY TESTING AND TREATMENT MARKET 2021-2028

Lifesciences | Diagnostic & Biotechnology

GLOBAL INFERTILITY TESTING AND TREATMENT MARKET 2021-2028

Market by Gender, End-user, and Geography | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

After a detailed analysis, Triton Market Research’s report has determined that the global infertility testing and treatment market is expected to display an upward trend in terms of revenue. In addition, it is estimated to grow at a CAGR of 10.15% during the forecasting years 2021-2028. The market accounted for $13.43 billion in 2020 and is expected to reach $32.94 billion by 2028.


Report scope can be customized per your requirements. Request For Customization

Globally, infertility is growing due to poor nutrition, stress, delayed marriages, increased work hours, changing lifestyles, and environmental pollution, among others. Thus, more people are visiting fertility clinics and medical institutes to seek treatments for infertility due to these factors. This has augmented the growth of the infertility testing and treatment market.

Triton’s report on the infertility testing and treatment market report gives a detailed analysis of the key insight, Porter’s five forces analysis, key buying impact analysis, market attractiveness index, industry components, vendor scorecard, and impact of COVID-19 on the market.

The rise in stress and lifestyle disorders, rising trends in delayed marriages and pregnancies, enhancement in treatments, and supportive governmental measures are driving the growth of the studied market. Stress and Obesity have a detrimental impact on fertility. Furthermore, the delay in marriages owing to work commitments, coupled with late pregnancies, is another set of factors supporting the market’s growth. As per various studies, fertility begins to decline after a certain age, lowering the fertility of an individual.

Factors such as technological advancements in time-lapse technology may generate new opportunities for the studied market. Time-lapse technology permits scientists to understand the development of embryos and helps them monitor the development of IVF embryos before transferring them into the womb. Further, this technology’s use gives a precise understanding of the embryos indicating the risk of having chromosomal abnormalities.

However, the high cost, social taboo pertaining to infertility, and risk associated with treatments are hampering the market’s growth. Infertility treatment costs are quite high, which restricts the majority of people to seek this treatment. Moreover, the lack of a 100% guarantee of the treatment’s success challenges the overall growth of the infertility testing and treatment market.



Major geographies covered in the infertility testing and treatment market are:

•           North America: United States and Canada

•           Europe: United Kingdom, Germany, France, Italy, Spain, Russia, and Rest of Europe

•           Asia-Pacific: China, Japan, India, South Korea, ASEAN countries, Australia & New Zealand, and Rest of Asia-Pacific

•           Latin America: Brazil, Mexico, and Rest of Latin America

•           Middle East and Africa: United Arab Emirates, Turkey, Saudi Arabia, South Africa, and Rest of Middle East & Africa

The infertility testing and treatment market, in this report, is segmented as:

•           Based on Gender:

           o          Male

                      •          Male Infertility Testing

                                 o         DNA Fragmentation

                                 o         Oxidative Stress Analysis

                                 o         Sperm Penetration Assay

                                 o         Computer-Assisted Semen Analysis (CASA)

                                 o         Sperm Agglutination

                                 o         Microscopic Examination

                                 o         Others

                      •          Male Infertility Treatment

                                 o         Medication

                                 o         Assisted Reproductive Technology & Varicocele Surgery

           o          Female

                      •          Female Infertility Testing

                                o          Ovulation Testing

                                o          Hysterosalpingography

                                o          Laparoscopy

                                o          Transvaginal Ultrasound

                                o          Ovarian Reserve Testing

                                o          Hormonal Level Testing

                                o          Others

                      •          Female Infertility Treatment

                                o          IVF with ICSI

                                o          IUI

                                o          IVF without ICSI

                                o          Surrogacy

                                o          Others

•           Based on End-user:

           o          Fertility and Surgical Centers

           o          Hospitals and Research Laboratories

           o          Cryobanks

The major companies in the infertility testing and treatment market are Create Fertility Centre, Genea Ltd, Fujifilm Irvine Scientific, EMD Group (Merck KGAA), Bangkok IVF Center, Vitrolife AB, Progyny, Ferring Pharmaceuticals, Adorfem, Endo International Plc, Cooper Surgical, Olympus Corporation, Cook Medical Inc, Labotect GmbH, and Halotech DNA.    

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. GLOBAL INFERTILITY TESTING AND TREATMENT MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. KEY INSIGHTS

2.1.1. GROWING DEMAND FOR LOW-COST PROCEDURES

2.1.2. INCREASING ACCEPTANCE OF DONOR EGGS

2.1.3. USE OF AI INCREASES THE SUCCESS OF IVF TREATMENTS

2.2. IMPACT OF COVID-19 ON INFERTILITY TESTING AND TREATMENT MARKET

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTE

2.3.3. BARGAINING POWER OF SUPPLIERS

2.3.4. BARGAINING POWER OF BUYERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. KEY BUYING IMPACT ANALYSIS

2.4.1. TREATMENT OPTIONS

2.4.2. QUALITY OF MEDICAL PROCEDURES

2.4.3. PRICE OF TREATMENTS

2.4.4. SHIFT TOWARDS MEDICAL TOURISM

2.4.5. REIMBURSEMENT

2.5. MARKET ATTRACTIVENESS MATRIX

2.6. INDUSTRY COMPONENTS

2.6.1. RAW MATERIAL PROCUREMENT

2.6.2. MANUFACTURING

2.6.3. SUPPLY LOGISTICS

2.6.4. DISTRIBUTION CHANNELS

2.6.5. END-USERS

2.7. VENDOR SCORECARD

2.8. KEY MARKET STRATEGIES

2.8.1. CONTRACTS & PARTNERSHIPS

2.8.2. ACQUISITIONS & MERGERS

2.8.3. NEW PRODUCT LAUNCHES

2.9. MARKET DRIVERS

2.9.1. GROWTH IN STRESS AND LIFESTYLE DISORDERS

2.9.2. RISING TREND IN DELAYED MARRIAGES AND PREGNANCIES

2.9.3. IMPROVEMENTS IN TREATMENTS

2.9.4. GOVERNMENT SUPPORT

2.10. MARKET CHALLENGES

2.10.1. HIGH COST

2.10.2. SOCIAL TABOO PERTAINING TO INFERTILITY

2.10.3. RISKS ASSOCIATED WITH TREATMENTS

2.11. MARKET OPPORTUNITIES

2.11.1. TECHNOLOGY ADVANCEMENTS IN TIME-LAPSE TECHNOLOGY

2.11.2. ADVANCES IN EMBRYO BIOPSY AND GENETIC SCREENING

3. GLOBAL INFERTILITY TESTING AND TREATMENT MARKET – BY GENDER

3.1. MALE

3.1.1. MALE INFERTILITY TESTING

3.1.1.1. DNA FRAGMENTATION

3.1.1.2. OXIDATIVE STRESS ANALYSIS

3.1.1.3. SPERM PENETRATION ASSAY

3.1.1.4. COMPUTER-ASSISTED SEMEN ANALYSIS (CASA)

3.1.1.5. SPERM AGGLUTINATION

3.1.1.6. MICROSCOPIC EXAMINATION

3.1.1.7. OTHERS

3.1.2.   MALE INFERTILITY TREATMENT

3.1.2.1. MEDICATION

3.1.2.2. ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY

3.2. FEMALE

3.2.1. FEMALE INFERTILITY TESTING

3.2.1.1. OVULATION TESTING

3.2.1.2. HYSTEROSALPINGOGRAPHY

3.2.1.3. LAPAROSCOPY

3.2.1.4. TRANSVAGINAL ULTRASOUND

3.2.1.5. OVARIAN RESERVE TESTING

3.2.1.6. HORMONAL LEVEL TESTING

3.2.1.7. OTHERS

3.2.2. FEMALE INFERTILITY TREATMENT

3.2.2.1. IVF WITH ICSI

3.2.2.2. IUI

3.2.2.3. IVF WITHOUT ICSI

3.2.2.4. SURROGACY

3.2.2.5. THERS

4. GLOBAL INFERTILITY TESTING AND TREATMENT MARKET - BY END-USER

4.1. FERTILITY AND SURGICAL CENTERS

4.2. HOSPITALS & RESEARCH LABORATORIES

4.3. CRYOBANKS

5. GLOBAL INFERTILITY TESTING AND TREATMENT MARKET – REGIONAL OUTLOOK

5.1. NORTH AMERICA

5.1.1. MARKET BY GENDER

5.1.1.1. MARKET BY MALE

5.1.1.1.1. MARKET BY MALE INFERTILITY TESTING

5.1.1.1.2. MARKET BY MALE INFERTILITY TREATMENT

5.1.1.2. MARKET BY FEMALE

5.1.1.2.1. MARKET BY FEMALE INFERTILITY TESTING

5.1.1.2.2. MARKET BY FEMALE INFERTILITY TREATMENT

5.1.2. MARKET BY END-USER

5.1.3. COUNTRY ANALYSIS

5.1.3.1. UNITED STATES

5.1.3.2. CANADA

5.2. EUROPE

5.2.1. MARKET BY GENDER

5.2.1.1. MARKET BY MALE

5.2.1.1.1. MARKET BY MALE INFERTILITY TESTING

5.2.1.1.2. MARKET BY MALE INFERTILITY TREATMENT

5.2.1.2. MARKET BY FEMALE

5.2.1.2.1. MARKET BY FEMALE INFERTILITY TESTING

5.2.1.2.2. MARKET BY FEMALE INFERTILITY TREATMENT

5.2.2. MARKET BY END-USER

5.2.3. COUNTRY ANALYSIS

5.2.3.1. UNITED KINGDOM

5.2.3.2. GERMANY

5.2.3.3. FRANCE

5.2.3.4. SPAIN

5.2.3.5. ITALY

5.2.3.6. RUSSIA

5.2.3.7. REST OF EUROPE

5.3. ASIA-PACIFIC

5.3.1. MARKET BY GENDER

5.3.1.1. MARKET BY MALE

5.3.1.1.1. MARKET BY MALE INFERTILITY TESTING

5.3.1.1.2. MARKET BY MALE INFERTILITY TREATMENT

5.3.1.2. MARKET BY FEMALE

5.3.1.2.1. MARKET BY FEMALE INFERTILITY TESTING

5.3.1.2.2. MARKET BY FEMALE INFERTILITY TREATMENT

5.3.2. MARKET BY END-USER

5.3.3. COUNTRY ANALYSIS

5.3.3.1. CHINA

5.3.3.2. JAPAN

5.3.3.3. INDIA

5.3.3.4. SOUTH KOREA

5.3.3.5. ASEAN COUNTRIES

5.3.3.6. AUSTRALIA & NEW ZEALAND

5.3.3.7. REST OF ASIA-PACIFIC

5.4. LATIN AMERICA

5.4.1. MARKET BY GENDER

5.4.1.1. MARKET BY MALE

5.4.1.1.1. MARKET BY MALE INFERTILITY TESTING

5.4.1.1.2. MARKET BY MALE INFERTILITY TREATMENT

5.4.1.2. MARKET BY FEMALE

5.4.1.2.1. MARKET BY FEMALE INFERTILITY TESTING

5.4.1.2.2. MARKET BY FEMALE INFERTILITY TREATMENT

5.4.2. MARKET BY END-USER

5.4.3. COUNTRY ANALYSIS

5.4.3.1. BRAZIL

5.4.3.2. MEXICO

5.4.3.3. REST OF LATIN AMERICA

5.5. MIDDLE EAST AND AFRICA

5.5.1. MARKET BY GENDER

5.5.1.1. MARKET BY MALE

5.5.1.1.1. MARKET BY MALE INFERTILITY TESTING

5.5.1.1.2. MARKET BY MALE INFERTILITY TREATMENT

5.5.1.2. MARKET BY FEMALE

5.5.1.2.1. MARKET BY FEMALE INFERTILITY TESTING

5.5.1.2.2. MARKET BY FEMALE INFERTILITY TREATMENT

5.5.2. MARKET BY END-USER

5.5.3. COUNTRY ANALYSIS

5.5.3.1. UNITED ARAB EMIRATES

5.5.3.2. TURKEY

5.5.3.3. SAUDI ARABIA

5.5.3.4. SOUTH AFRICA

5.5.3.5. REST OF MIDDLE EAST & AFRICA

6. COMPETITIVE LANDSCAPE

6.1. ADORFEM

6.2. BANGKOK IVF CENTER

6.3. COOK MEDICAL INC

6.4. COOPER SURGICAL

6.5. CREATE FERTILITY CENTRE

6.6. EMD GROUP (MERCK KGAA)

6.7. ENDO INTERNATIONAL PLC

6.8. FERRING PHARMACEUTICALS

6.9. HALOTECH DNA

6.10. GENEA LTD

6.11. FUJIFILM IRVINE SCIENTIFIC

6.12. VITROLIFE AB

6.13. LABOTECT GMBH

6.14. OLYMPUS CORPORATION

6.15. PROGYNY

7. METHODOLOGY & SCOPE

7.1. RESEARCH SCOPE & DELIVERABLES

7.2. SOURCES OF DATA

7.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2: MARKET ATTRACTIVENESS MATRIX

TABLE 3: VENDOR SCORECARD

TABLE 4: LIST OF CONTRACTS & PARTNERSHIPS

TABLE 5: LIST OF ACQUISITIONS & MERGERS

TABLE 6: LIST OF NEW PRODUCT LAUNCHES

TABLE 7: AVERAGE COST COMPARISON OF INFERTILITY TREATMENTS

TABLE 8: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)

TABLE 9: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)

TABLE 10: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

TABLE 11: PROS AND CONS OF DNA SHARING METHODS

TABLE 12: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

TABLE 13: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)

TABLE 14: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

TABLE 15: COST OF OVULATION TESTING KITS IN THE US

TABLE 16: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

TABLE 17: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY END-USER, 2021-2028, (IN $ MILLION)

TABLE 18: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 19: NORTH AMERICA INFERTILITY TESTING AND TREATMENT MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 20: NORTH AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)

TABLE 21: NORTH AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)

TABLE 22: NORTH AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

TABLE 23: NORTH AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

TABLE 24: NORTH AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)

TABLE 25: NORTH AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

TABLE 26: NORTH AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

TABLE 27: NORTH AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 28: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 29: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)

TABLE 30: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)

TABLE 31: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

TABLE 32: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

TABLE 33: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)

TABLE 34: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

TABLE 35: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

TABLE 36: EUROPE INFERTILITY TESTING AND TREATMENT MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 37: ASIA-PACIFIC INFERTILITY TESTING AND TREATMENT MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 38: ASIA-PACIFIC INFERTILITY TESTING AND TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)

TABLE 39: ASIA-PACIFIC INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)

TABLE 40: ASIA-PACIFIC INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

TABLE 41: ASIA-PACIFIC INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

TABLE 42: ASIA-PACIFIC INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)

TABLE 43: ASIA-PACIFIC INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

TABLE 44: ASIA-PACIFIC INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

TABLE 45: ASIA-PACIFIC INFERTILITY TESTING AND TREATMENT MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 46: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 47: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)

TABLE 48: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)

TABLE 49: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

TABLE 50: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

TABLE 51: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)

TABLE 52: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

TABLE 53: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

TABLE 54: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 55: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 56: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)

TABLE 57: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)

TABLE 58: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

TABLE 59: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

TABLE 60: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)

TABLE 61: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

TABLE 62: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

TABLE 63: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1: PORTER’S FIVE FORCES ANALYSIS

FIGURE 2: KEY BUYING IMPACT ANALYSIS

FIGURE 3: INDUSTRY COMPONENTS

FIGURE 4: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY GENDER, 2020 & 2028 (IN %)

FIGURE 5: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)

FIGURE 6: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2020 & 2028

FIGURE 7: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

FIGURE 8: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2020 & 2028 (IN %)

FIGURE 9: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY DNA FRAGMENTATION, 2021-2028 (IN $ MILLION)

FIGURE 10: CAUSES OF SPERM DNA FRAGMENTATION

FIGURE 11: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY OXIDATIVE STRESS ANALYSIS, 2021-2028 (IN $ MILLION)

FIGURE 12: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY SPERM PENETRATION ASSAY, 2021-2028 (IN $ MILLION)

FIGURE 13: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS (CASA), 2021-2028 (IN $ MILLION)

FIGURE 14: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY SPERM AGGLUTINATION, 2021-2028 (IN $ MILLION)

FIGURE 15: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY MICROSCOPIC EXAMINATION, 2021-2028 (IN $ MILLION)

FIGURE 16: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 17: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

FIGURE 18: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2020 & 2028 (IN %)

FIGURE 19: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY MEDICATION, 2021-2028 (IN $ MILLION)

FIGURE 20: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 21: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)

FIGURE 22: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2020 & 2028 (IN %)

FIGURE 23: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

FIGURE 24: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2020 & 2028

FIGURE 25: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY OVULATION TESTING, 2021-2028 (IN $ MILLION)

FIGURE 26: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY HYSTEROSALPINGOGRAPHY, 2021-2028 (IN $ MILLION)

FIGURE 27: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)

FIGURE 28: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY TRANSVAGINAL ULTRASOUND, 2021-2028 (IN $ MILLION)

FIGURE 29: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY OVARIAN RESERVE TESTING, 2021-2028 (IN $ MILLION)

FIGURE 30: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY HORMONAL LEVEL TESTING, 2021-2028 (IN $ MILLION)

FIGURE 31: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 32: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

FIGURE 33: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2020 & 2028 (IN %)

FIGURE 34: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY IVF WITH ICSI, 2021-2028 (IN $ MILLION)

FIGURE 35: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY IUI, 2021-2028 (IN $ MILLION)

FIGURE 36: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY IVF WITHOUT ICSI, 2021-2028 (IN $ MILLION)

FIGURE 37: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY SURROGACY, 2021-2028 (IN $ MILLION)

FIGURE 38: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 39: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY END-USER, 2020 & 2028 (IN %)

FIGURE 40: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY FERTILITY AND SURGICAL CENTERS, 2021-2028 (IN $ MILLION)

FIGURE 41: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY HOSPITALS & RESEARCH LABORATORIES, 2021-2028 (IN $ MILLION)

FIGURE 42: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, BY CRYOBANKS, 2021-2028 (IN $ MILLION)

FIGURE 43: GLOBAL INFERTILITY TESTING AND TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 44: UNITED STATES INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 45: CANADA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 46: UNITED KINGDOM INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 47: GERMANY INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 48: FRANCE INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 49: SPAIN INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 50: ITALY INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 51: RUSSIA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 52: REST OF EUROPE INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 53: CHINA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 54: JAPAN INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 55: INDIA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 56: SOUTH KOREA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 57: ASEAN COUNTRIES INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 58: AUSTRALIA & NEW ZEALAND INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 59: REST OF ASIA-PACIFIC INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 60: BRAZIL INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 61: MEXICO INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 62: REST OF LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 63: UNITED ARAB EMIRATES INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 64: TURKEY INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 65: SAUDI ARABIA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 66: SOUTH AFRICA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 67: REST OF MIDDLE EAST & AFRICA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;